Please Note:
This profile was automatically generated using 3 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 3 references found on the Internet. This information has not been verified. Learn more...
Web References
-
1. ThinkEquity Partners
www.thinkequity.com/research/t - [Cached]Published on: 4/22/2007 Last Visited: 4/22/2007
David Lo, Vice President, Life Science R&D Tools Research
...
David joined ThinkEquity Partners LLC in February 2005 as a senior research analyst covering Life Science R&D tools. Before joining ThinkEquity Partners, David was an equity research analyst at Sidoti & Company LLC. Previously, David worked for the Chiron Corporation and Bayer Diagnostics as a researcher developing nucleic acid infectious disease diagnostics. David received his MBA from Fordham University and a BS in Microbiology & Chemistry from San Jose State University. -
2. Earnings Preview: Invitrogen: Financial News - Yahoo! Finance
biz.yahoo.com/ap/061025/earnin - [Cached]Published on: 10/25/2006 Last Visited: 10/25/2006
ThinkEquity Partners analyst David Lo also took an optimistic view of the company, saying it will likely meet his estimate of 76 cents per share on $311 million in revenue. -
3. Wall Street Letter - Your window to Wall Street for more than 30 years
new.wallstreetletter.com/defau - [Cached]Published on: 5/6/2005 Last Visited: 9/26/2006
ThinkEquity Partners last week promoted David Lo to senior research analyst in a new position covering life science research and development tools.

